Analytical Cannabis caught up with Dr. Arora to discuss his podcast, his role as an advisor to cannabis and psychedelic businesses, and what the future holds for both sectors.
The move would enable the Company to synthesize, process and distribute pharmaceutical grade 3,4-Methylenedioxymethamphetamine (“MDMA”), among other substances, at its Princeton, British Columbia facility.
New research published in the journal Frontiers in Pharmacology has found that the mystical experiences induced by psilocybin are closely linked to long-lasting positive psychological effects in healthy individuals.
Can psychedelic drugs help scientists to solve their technical problems? Yes, according to one recent review.
While effective treatments for opioid addictions have been available, this could be the first dedicated treatment for cocaine addiction, which is a global crisis.
From next year, Canadians living in the province of British Columbia will be able to possess opioids, cocaine, methamphetamine, and MDMA, the country’s government has announced.
The psychedelics company Ceruvia Lifesciences is offering to supply LSD, at no cost, to qualified researchers.
Researchers from the University of California, Davis, and the University of Colorado Anschutz Medical Campus are about to start a new project to discover new, non-hallucinogenic treatments for substance use disorders.
How does psilocybin act on the brain to relieve depression? Clare Tweedy, a teaching fellow at the University of Leeds, explains all in this feature, courtesy of the Conversation.